Literature DB >> 2743078

An evaluation of the structure-activity relationships of a series of analogues of mephenesin and strychnine on the response to pressure in mice.

F Bowser-Riley1, S Daniels, W A Hill, E B Smith.   

Abstract

1. A range of compounds structurally related to the centrally acting muscle relaxant mephenesin and to the chemical convulsant strychnine were synthesized and tested for their ability to alter the threshold pressures for the onset of high pressure convulsions in mice. 2. The ability of both groups of compounds to alter the threshold pressure for convulsions was found to be dependent on the nature of a simple molecular skeleton. Thus, compounds that possessed a negatively polarized group located both in the same plane as and some 4.5 A from an aromatic nucleus increased the thresholds whereas compounds with a positively polarized group at the same location reduced the thresholds. 3. These findings support the suggestion that pressure elicits convulsions via a selection action on a receptor protein complex rather than via some general perturbation of the lipid regions of cellular membranes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2743078      PMCID: PMC1854426          DOI: 10.1111/j.1476-5381.1989.tb11885.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

1.  Central depressant and anticonvulsant properties of glycerol ethers isomeric with mephenesin.

Authors:  F M BERGER
Journal:  J Pharmacol Exp Ther       Date:  1952-08       Impact factor: 4.030

2.  Mechanistic studies on the high pressure neurological syndrome.

Authors:  F Bowser-Riley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1984-01-07       Impact factor: 6.237

Review 3.  The nature of the site of general anesthesia.

Authors:  K W Miller
Journal:  Int Rev Neurobiol       Date:  1985       Impact factor: 3.230

4.  Aryloxypropane derivatives. II. The synthesis of some aryloxypropanolamines for study as local anaesthetics.

Authors:  V PETROW; O STEPHENSON; A J THOMAS
Journal:  J Pharm Pharmacol       Date:  1956-09       Impact factor: 3.765

5.  Drugs that increase gamma-aminobutyric acid transmission protect against the high pressure neurological syndrome.

Authors:  A R Bichard; H J Little
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

6.  Effect of excitatory amino acid antagonists on the high pressure neurological syndrome in rats.

Authors:  B Wardley-Smith; B S Meldrum
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

7.  Investigations into the origin of the high pressure neurological syndrome: the interaction between pressure, strychnine and 1,2-propandiols in the mouse.

Authors:  F Bowser-Riley; S Daniels; E B Smith
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

  7 in total
  1 in total

1.  Possible NMDA antagonist properties of drugs that affect high pressure neurological syndrome.

Authors:  M A Shuker; F Bowser-Riley; S N Davies
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.